1 | 100 µg Brimonidine Tartrate Implant | 1件: Brimonidine Brimonidine | 2件: D02076
D02076
,
D07540
| 3件: ADRA2A ADRA2A, ADRA2B, ADRA2C 💬 | 2件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬 | 1件: 90 90 |
2 | 200 µg Brimonidine Tartrate Implant | 1件: Brimonidine Brimonidine | 2件: D02076
D02076
,
D07540
| 3件: ADRA2A ADRA2A, ADRA2B, ADRA2C 💬 | 2件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬 | 1件: 90 90 |
3 | 400 µg Brimonidine Tartrate Implant | 1件: Brimonidine Brimonidine | 2件: D02076
D02076
,
D07540
| 3件: ADRA2A ADRA2A, ADRA2B, ADRA2C 💬 | 2件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬 | 1件: 90 90 |
4 | 4D-125 IVT Injection | - | - | - | - | 1件: 90 90 |
5 | 9715X | - | - | - | - | 1件: 90 90 |
6 | 9741X | - | - | - | - | 1件: 90 90 |
7 | 9742X | - | - | - | - | 1件: 90 90 |
8 | AAV-RPGR | - | - | - | - | 1件: 90 90 |
9 | AAV2-REP1 | - | - | - | - | 1件: 90 90 |
10 | AAV2/5-hPDE6B | - | - | - | - | 1件: 90 90 |
11 | AAV2/5-hRKp.RPGR | - | - | - | - | 1件: 90 90 |
12 | AAV5-HRKP.RPGR | - | - | - | - | 1件: 90 90 |
13 | AAV8-RPGR | - | - | - | - | 1件: 90 90 |
14 | Acetate | 1件: Acetate Acetate | - | - | - | 43件: 1 1, 2, 6, 10, 13, 35, 40, 46, 49, 51, 60, 64, 67, 70, 71, 73, 75, 76, 78, 79, 81, 83, 85, 86, 88, 90, 96, 97, 113, 145, 156, 162, 171, 206, 222, 224, 225, 227, 235, 265, 288, 298, 299 |
15 | Acetazolamide | 1件: Acetazolamide Acetazolamide | 2件: D00218
D00218
,
D01196
| 13件: CA1 CA1, CA12, CA13, CA14, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA8, CA9 💬 | 7件: Bile secretion Bile secretion, Collecting duct acid secretion, Gastric acid secretion, Metabolic pathways, Nitrogen metabolism, Pancreatic secretion, Proximal tubule bicarbonate reclamation 💬 | 6件: 13 13, 90, 115, 155, 225, 230 |
16 | Acetylcysteine | 1件: Acetylcysteine Acetylcysteine | 1件: D00221
D00221
| - | - | 20件: 6 6, 13, 19, 20, 34, 49, 51, 53, 58, 85, 90, 94, 111, 164, 193, 233, 296, 298, 299, 337 |
17 | Adeno-associated virus type 2 vector encoding Rab escort protein 1 | - | - | - | - | 1件: 90 90 |
18 | Aflibercept | 1件: Aflibercept Aflibercept | 1件: D09574
D09574
| 3件: PGF PGF, VEGFA, VEGFB 💬 | 24件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Bladder cancer, Calcium signaling pathway, Chemical carcinogenesis - reactive oxygen species, Chemical carcinogenesis - receptor activation, EGFR tyrosine kinase inhibitor resistance, Fluid shear stress and atherosclerosis, Focal adhesion, HIF-1 signaling pathway, Human cytomegalovirus infection, Human papillomavirus infection, Kaposi sarcoma-associated herpesvirus infection, MAPK signaling pathway, MicroRNAs in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Relaxin signaling pathway, Renal cell carcinoma, Rheumatoid arthritis, VEGF signaling pathway 💬 | 2件: 90 90, 166 |
19 | Alga Dunaliella Bardawil | - | - | - | - | 1件: 90 90 |
20 | Alga Dunaliella Bardawil powder | - | - | - | - | 1件: 90 90 |
21 | Alga Dunaliella Bardawill | - | - | - | - | 1件: 90 90 |
22 | ALLOGENEIC NEURAL RETINA-DERIVED HUMAN NEURAL RETINAL PROGENITOR CELLS EX VIVO EXPANDED | - | - | - | - | 1件: 90 90 |
23 | AlloRx | - | - | - | - | 8件: 2 2, 6, 13, 46, 51, 85, 90, 226 |
24 | Antioxidants | - | - | - | - | 3件: 90 90, 298, 310 |
25 | Betamethasone | 1件: Betamethasone Betamethasone | 7件: D00244
D00244
,
D00972
,
D01357
,
D01402
,
D01637
,
D02032
,
D02286
| 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 7件: 2 2, 28, 46, 83, 90, 96, 235 |
26 | BIIB112 | - | - | - | - | 1件: 90 90 |
27 | Blue light-absorbing sunglasses | - | - | - | - | 1件: 90 90 |
28 | BMMNCs | - | - | - | - | 1件: 90 90 |
29 | Botaretigene sparoparvovec | - | - | - | - | 1件: 90 90 |
30 | Brimonidine | 1件: Brimonidine Brimonidine | 2件: D02076
D02076
,
D07540
| 3件: ADRA2A ADRA2A, ADRA2B, ADRA2C 💬 | 2件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬 | 2件: 13 13, 90 |
31 | Brimonidine tartrate | 1件: Brimonidine Brimonidine | 2件: D02076
D02076
,
D07540
| 3件: ADRA2A ADRA2A, ADRA2B, ADRA2C 💬 | 2件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬 | 2件: 13 13, 90 |
32 | Brimonidine Tartrate Posterior Segment Drug Delivery System (Brimo PS DDS) Applicator System | 1件: Brimonidine Brimonidine | 2件: D02076
D02076
,
D07540
| 3件: ADRA2A ADRA2A, ADRA2B, ADRA2C 💬 | 2件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬 | 1件: 90 90 |
33 | BS01 | - | - | - | - | 1件: 90 90 |
34 | Cannabis | 1件: Medical Cannabis Medical Cannabis | - | - | - | 9件: 2 2, 6, 13, 19, 46, 90, 96, 97, 271 |
35 | Carbidopa | 1件: Carbidopa Carbidopa | 1件: D00558
D00558
| 1件: DDC DDC 💬 | 9件: Alcoholism Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬 | 9件: 2 2, 4, 6, 13, 17, 90, 140, 164, 201 |
36 | CD34+ bone marrow stem cells intravitreal | - | - | - | - | 1件: 90 90 |
37 | Cholesterol | 1件: Cholesterol Cholesterol | 1件: D00040
D00040
| - | - | 6件: 19 19, 90, 160, 259, 261, 310 |
38 | Ciliary neurotrophic factor | 1件: Ciliary neurotrophic factor Ciliary neurotrophic factor | - | - | - | 1件: 90 90 |
39 | Ciliary Neurotrophic Factor Implant NT-501 | 1件: Ciliary neurotrophic factor Ciliary neurotrophic factor | - | - | - | 1件: 90 90 |
40 | Circadin | 1件: Melatonin Melatonin | 1件: D08170
D08170
| 2件: MTNR1A MTNR1A, MTNR1B 💬 | 2件: Circadian entrainment Circadian entrainment, Neuroactive ligand-receptor interaction 💬 | 3件: 6 6, 13, 90 |
41 | Circadin 2 mg | 1件: Melatonin Melatonin | 1件: D08170
D08170
| 2件: MTNR1A MTNR1A, MTNR1B 💬 | 2件: Circadian entrainment Circadian entrainment, Neuroactive ligand-receptor interaction 💬 | 1件: 90 90 |
42 | CIRCADIN 2 mg comprimidos de liberación prolongada | 1件: Melatonin Melatonin | 1件: D08170
D08170
| 2件: MTNR1A MTNR1A, MTNR1B 💬 | 2件: Circadian entrainment Circadian entrainment, Neuroactive ligand-receptor interaction 💬 | 1件: 90 90 |
43 | CNS10-NPC implantation | - | - | - | - | 1件: 90 90 |
44 | CNTO 2476 | - | - | - | - | 1件: 90 90 |
45 | Combination Product: PRP combined Magnovision | - | - | - | - | 1件: 90 90 |
46 | Compound thrombosis capsule sig: 1.5g/tid | - | - | - | - | 1件: 90 90 |
47 | Conditioned Medium (CM) | - | - | - | - | 1件: 90 90 |
48 | Continuous oxygen | 1件: Oxygen Oxygen | 1件: D00003
D00003
| - | - | 1件: 90 90 |
49 | COQUN | - | - | - | - | 1件: 90 90 |
50 | Cornstarch | 1件: Starch, corn Starch, corn | 1件: D05297
D05297
| - | - | 2件: 90 90, 257 |
51 | Cornstarch control | 1件: Starch, corn Starch, corn | 1件: D05297
D05297
| - | - | 1件: 90 90 |
52 | Cotoretigene Toliparvovec | - | - | - | - | 1件: 90 90 |
53 | CPK850 | - | - | - | - | 1件: 90 90 |
54 | Cyclosporine | 1件: Cyclosporine Cyclosporine | 1件: D00184
D00184
| 5件: PPP3CA PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 | 33件: Alzheimer disease Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬 | 37件: 11 11, 19, 20, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 56, 58, 60, 61, 62, 63, 64, 65, 90, 95, 97, 107, 162, 164, 222, 226, 228, 234, 283, 284, 285, 302 |
55 | Cysteine | 1件: Cysteine Cysteine | 2件: D00026
D00026
,
D02326
| - | - | 11件: 6 6, 13, 19, 34, 84, 85, 88, 90, 254, 296, 310 |
56 | DDS | - | - | - | - | 1件: 90 90 |
57 | Dexamethasone | 1件: Dexamethasone Dexamethasone | 9件: D00292
D00292
,
D00975
,
D01510
,
D01615
,
D01632
,
D01948
,
D02174
,
D02591
,
D02592
| 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 25件: 13 13, 14, 16, 28, 35, 46, 53, 63, 64, 65, 70, 74, 75, 81, 84, 90, 96, 97, 162, 222, 235, 257, 283, 296, 299 |
58 | Dexamethasone injection | 1件: Dexamethasone Dexamethasone | 9件: D00292
D00292
,
D00975
,
D01510
,
D01615
,
D01632
,
D01948
,
D02174
,
D02591
,
D02592
| 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 90 90 |
59 | Diagnostic Test: Ocular Coherence Tomography-Angiography (OCT-A) | - | - | - | - | 2件: 90 90, 301 |
60 | Docosahexaenoic acid | 1件: Doconexent Doconexent | - | - | - | 7件: 6 6, 49, 90, 94, 240, 299, 301 |
61 | Dorzolamide | 1件: Dorzolamide Dorzolamide | 2件: D00653
D00653
,
D07871
| 13件: CA1 CA1, CA12, CA13, CA14, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA8, CA9 💬 | 7件: Bile secretion Bile secretion, Collecting duct acid secretion, Gastric acid secretion, Metabolic pathways, Nitrogen metabolism, Pancreatic secretion, Proximal tubule bicarbonate reclamation 💬 | 1件: 90 90 |
62 | Eylea | 1件: Aflibercept Aflibercept | 1件: D09574
D09574
| 3件: PGF PGF, VEGFA, VEGFB 💬 | 24件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Bladder cancer, Calcium signaling pathway, Chemical carcinogenesis - reactive oxygen species, Chemical carcinogenesis - receptor activation, EGFR tyrosine kinase inhibitor resistance, Fluid shear stress and atherosclerosis, Focal adhesion, HIF-1 signaling pathway, Human cytomegalovirus infection, Human papillomavirus infection, Kaposi sarcoma-associated herpesvirus infection, MAPK signaling pathway, MicroRNAs in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Relaxin signaling pathway, Renal cell carcinoma, Rheumatoid arthritis, VEGF signaling pathway 💬 | 2件: 90 90, 166 |
63 | Fluocinolone | 1件: Fluocinolone Fluocinolone | - | - | - | 1件: 90 90 |
64 | Fluocinolone Acetonide | 2件: Fluocinolone Fluocinolone, Fluocinolone acetonide | 1件: D01825
D01825
| 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 90 90 |
65 | Gene Therapy Product-vMCO-010 | - | - | - | - | 1件: 90 90 |
66 | Gene Therapy product:vMCO-I | - | - | - | - | 1件: 90 90 |
67 | Genetic: AAV5-RPGR | - | - | - | - | 1件: 90 90 |
68 | Genetic: AAV5-RPGR 2e11 | - | - | - | - | 1件: 90 90 |
69 | Genetic: AAV5-RPGR 4e11 | - | - | - | - | 1件: 90 90 |
70 | Ginkgo | 1件: Ginkgo biloba Ginkgo biloba | - | - | - | 5件: 6 6, 13, 18, 47, 90 |
71 | Ginkgo biloba | 1件: Ginkgo biloba Ginkgo biloba | - | - | - | 4件: 13 13, 18, 47, 90 |
72 | Ginkgo biloba pills sig: 300mg/tid | 1件: Ginkgo biloba Ginkgo biloba | - | - | - | 1件: 90 90 |
73 | GS030-DP | - | - | - | - | 1件: 90 90 |
74 | HORA-PDE6B (AAV2/5.hPDE6B) | - | - | - | - | 1件: 90 90 |
75 | HRPC | - | - | - | - | 1件: 90 90 |
76 | HRPC DP | - | - | - | - | 1件: 90 90 |
77 | Human Embryonic Stem Cell Derived Retinal Pigment Epithelium (RPE) | - | - | - | - | 1件: 90 90 |
78 | Human primary Retinal Pigment Epithelial (HuRPE) cells | - | - | - | - | 1件: 90 90 |
79 | Human retinal progenitor cells | - | - | - | - | 1件: 90 90 |
80 | Human Retinal Progenitor Cells Drug Product | - | - | - | - | 1件: 90 90 |
81 | Hydroxychloroquine | 1件: Hydroxychloroquine Hydroxychloroquine | 1件: D08050
D08050
| - | - | 27件: 13 13, 34, 41, 43, 44, 45, 46, 48, 49, 53, 56, 63, 66, 84, 89, 90, 96, 97, 107, 218, 222, 224, 234, 254, 271, 298, 299 |
82 | Hydroxychloroquine higher dose | 1件: Hydroxychloroquine Hydroxychloroquine | 1件: D08050
D08050
| - | - | 1件: 90 90 |
83 | Hydroxychloroquine lower dose | 1件: Hydroxychloroquine Hydroxychloroquine | 1件: D08050
D08050
| - | - | 1件: 90 90 |
84 | Hyperbaric oxygen therapy | 1件: Oxygen Oxygen | 1件: D00003
D00003
| - | - | 1件: 90 90 |
85 | Iluvien | 1件: Fluocinolone acetonide Fluocinolone acetonide | 1件: D01825
D01825
| 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 90 90 |
86 | Injection of stem cells in sub-tenon space of eye for the management of retinitis pigmentosa | - | - | - | - | 1件: 90 90 |
87 | Injection of stem cells in suprachoroidal space of eye for the management of Retinitis Pigmentosa | - | - | - | - | 1件: 90 90 |
88 | Intravitreal autologous CD34+ cells | - | - | - | - | 1件: 90 90 |
89 | Intravitreal injection of Autologous bone marrow Stem Cell | - | - | - | - | 1件: 90 90 |
90 | Intravitreal injection of autologous bone marrow stem cells | - | - | - | - | 1件: 90 90 |
91 | KIO-301 | - | - | - | - | 1件: 90 90 |
92 | Lentiviral vector containing MYO7A gene | - | - | - | - | 2件: 90 90, 303 |
93 | Lentiviral vector containing the human MY07A gene | - | - | - | - | 2件: 90 90, 303 |
94 | Levodopa | 1件: Levodopa Levodopa | 1件: D00059
D00059
| 5件: DRD1 DRD1, DRD2, DRD3, DRD4, DRD5 💬 | 11件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 8件: 2 2, 4, 6, 17, 90, 140, 164, 201 |
95 | Levodopa-Carbidopa | 2件: Carbidopa Carbidopa, Levodopa | 2件: D00059
D00059
,
D00558
| 6件: DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 | 16件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | 2件: 6 6, 90 |
96 | Lutein | 1件: Lutein Lutein | - | - | - | 3件: 13 13, 90, 164 |
97 | Lutein (10 or 30 mg/day) capsules | 1件: Lutein Lutein | - | - | - | 1件: 90 90 |
98 | Lycium Barbarum | - | - | - | - | 1件: 90 90 |
99 | Melatonin | 1件: Melatonin Melatonin | 1件: D08170
D08170
| 2件: MTNR1A MTNR1A, MTNR1B 💬 | 2件: Circadian entrainment Circadian entrainment, Neuroactive ligand-receptor interaction 💬 | 12件: 6 6, 8, 13, 37, 46, 49, 90, 97, 144, 145, 149, 202 |
100 | Minocycline | 1件: Minocycline Minocycline | 2件: D00850
D00850
,
D05045
| - | - | 13件: 2 2, 6, 8, 13, 46, 85, 90, 94, 162, 201, 206, 280, 299 |
101 | N-Acetyl Cysteine (NAC) | 1件: Cysteine Cysteine | 2件: D00026
D00026
,
D02326
| - | - | 1件: 90 90 |
102 | NAC | - | - | - | - | 5件: 34 34, 51, 85, 90, 299 |
103 | NAC effervescent tablets | - | - | - | - | 1件: 90 90 |
104 | Nerve Growt Factor - 2.5S | - | - | - | - | 1件: 90 90 |
105 | Nerve Growth Factor | 1件: Nerve Growth Factor Nerve Growth Factor | - | - | - | 3件: 3 3, 53, 90 |
106 | Nilvadipine | 1件: Nilvadipine Nilvadipine | 1件: D01908
D01908
| 4件: CACNA1C CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 | 37件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Alzheimer disease, Amphetamine addiction, Arrhythmogenic right ventricular cardiomyopathy, Calcium signaling pathway, Carbohydrate digestion and absorption, Cardiac muscle contraction, Cellular senescence, Chemical carcinogenesis - receptor activation, Cholinergic synapse, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, Dilated cardiomyopathy, Dopaminergic synapse, GABAergic synapse, Glutamatergic synapse, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Hypertrophic cardiomyopathy, Insulin secretion, Long-term potentiation, MAPK signaling pathway, Oxytocin signaling pathway, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction, Tight junction, Type II diabetes mellitus, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 90 90 |
107 | NPI-001 | - | - | - | - | 2件: 90 90, 303 |
108 | NT-501 | - | - | - | - | 2件: 90 90, 303 |
109 | Null | - | - | - | - | 16件: 6 6, 13, 15, 28, 37, 46, 49, 51, 63, 86, 90, 96, 97, 107, 145, 271 |
110 | Nutritional Supplement | - | - | - | - | 1件: 90 90 |
111 | OCU400 High Dose | - | - | - | - | 1件: 90 90 |
112 | OCU400 Low Dose | - | - | - | - | 1件: 90 90 |
113 | OCU400 Mid Dose | - | - | - | - | 1件: 90 90 |
114 | Other: Mock injection | - | - | - | - | 1件: 90 90 |
115 | Other: Observational | - | - | - | - | 1件: 90 90 |
116 | Other: Sham (no implant) | - | - | - | - | 1件: 90 90 |
117 | Other: Sham procedure | - | - | - | - | 1件: 90 90 |
118 | Other: Sham-procedure | - | - | - | - | 2件: 90 90, 303 |
119 | Other: Sham-procedure (dose cohort 1&2 only) | - | - | - | - | 2件: 90 90, 303 |
120 | Other: Standard of Care Sildenafil | 1件: Sildenafil Sildenafil | 2件: D02229
D02229
,
D08514
| 1件: PDE5A PDE5A 💬 | 3件: Metabolic pathways Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬 | 2件: 90 90, 301 |
121 | Other: Subconjunctival injection of saline | - | - | - | - | 1件: 90 90 |
122 | Other: Sugar pill | - | - | - | - | 1件: 90 90 |
123 | Other: Visual Acuity (VA) | - | - | - | - | 2件: 90 90, 301 |
124 | Oxygen | 1件: Oxygen Oxygen | 1件: D00003
D00003
| - | - | 20件: 6 6, 13, 19, 46, 49, 70, 84, 85, 86, 88, 90, 96, 97, 168, 193, 226, 271, 294, 299, 330 |
125 | Phosphate | 1件: Phosphate ion Phosphate ion | - | - | - | 33件: 2 2, 3, 6, 11, 12, 13, 15, 28, 36, 46, 49, 51, 53, 60, 62, 65, 70, 78, 81, 83, 90, 96, 97, 164, 235, 238, 256, 276, 283, 284, 285, 286, 299 |
126 | Platelet Rich Plasma | - | - | - | - | 2件: 46 46, 90 |
127 | Prescribe N-acetylcysteine tablets | 1件: Acetylcysteine Acetylcysteine | 1件: D00221
D00221
| - | - | 1件: 90 90 |
128 | PRP | - | - | - | - | 1件: 90 90 |
129 | PS | - | - | - | - | 4件: 6 6, 46, 90, 97 |
130 | QLT091001 | - | - | - | - | 1件: 90 90 |
131 | QR-1123 | - | - | - | - | 1件: 90 90 |
132 | QR-421a | - | - | - | - | 2件: 90 90, 303 |
133 | RAAV.hPDE6A vector | - | - | - | - | 1件: 90 90 |
134 | RAAV2tYF-GRK1-hRPGRco | - | - | - | - | 1件: 90 90 |
135 | RAAV2tYF-GRK1-RPGR | - | - | - | - | 1件: 90 90 |
136 | Recombinant adeno-associated viral vector serotype 2.7m8 containing the ChrimsonR-tdTomato gene | - | - | - | - | 1件: 90 90 |
137 | Recombinant Human Nerve Growth Factor (rhNGF) | 2件: Cenegermin Cenegermin, Nerve Growth Factor | 1件: D11028
D11028
| 1件: NGFR NGFR 💬 | 8件: Apoptosis - multiple species Apoptosis - multiple species, Cytokine-cytokine receptor interaction, MAPK signaling pathway, Neurotrophin signaling pathway, PI3K-Akt signaling pathway, Rap1 signaling pathway, Ras signaling pathway, Transcriptional misregulation in cancer 💬 | 2件: 53 53, 90 |
138 | Retinal pigment epitheliums transplantation | - | - | - | - | 1件: 90 90 |
139 | RhNGF | 1件: Cenegermin Cenegermin | 1件: D11028
D11028
| 1件: NGFR NGFR 💬 | 8件: Apoptosis - multiple species Apoptosis - multiple species, Cytokine-cytokine receptor interaction, MAPK signaling pathway, Neurotrophin signaling pathway, PI3K-Akt signaling pathway, Rap1 signaling pathway, Ras signaling pathway, Transcriptional misregulation in cancer 💬 | 2件: 53 53, 90 |
140 | RhNGF 180 µg/ml eye drops solution | 1件: Cenegermin Cenegermin | 1件: D11028
D11028
| 1件: NGFR NGFR 💬 | 8件: Apoptosis - multiple species Apoptosis - multiple species, Cytokine-cytokine receptor interaction, MAPK signaling pathway, Neurotrophin signaling pathway, PI3K-Akt signaling pathway, Rap1 signaling pathway, Ras signaling pathway, Transcriptional misregulation in cancer 💬 | 1件: 90 90 |
141 | RhNGF 60 µg/ml eye drops solution | 1件: Cenegermin Cenegermin | 1件: D11028
D11028
| 1件: NGFR NGFR 💬 | 8件: Apoptosis - multiple species Apoptosis - multiple species, Cytokine-cytokine receptor interaction, MAPK signaling pathway, Neurotrophin signaling pathway, PI3K-Akt signaling pathway, Rap1 signaling pathway, Ras signaling pathway, Transcriptional misregulation in cancer 💬 | 1件: 90 90 |
142 | RNA antisense oligonucleotide for intravitreal injection | - | - | - | - | 2件: 90 90, 303 |
143 | RST-001 | - | - | - | - | 1件: 90 90 |
144 | SAR421869 | - | - | - | - | 2件: 90 90, 303 |
145 | Sham | - | - | - | - | 3件: 90 90, 211, 303 |
146 | Sham Injection | - | - | - | - | 1件: 90 90 |
147 | Sildenafil | 1件: Sildenafil Sildenafil | 2件: D02229
D02229
,
D08514
| 1件: PDE5A PDE5A 💬 | 3件: Metabolic pathways Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬 | 17件: 6 6, 46, 50, 51, 85, 86, 90, 113, 210, 211, 212, 225, 226, 278, 294, 299, 301 |
148 | Sodium Valproate | 1件: Valproic acid Valproic acid | 1件: D00399
D00399
| 7件: ABAT ABAT, ALDH5A1, CACNA1G, CACNA1H, CACNA1I, GAD1, GAD2 💬 | 17件: Alanine, aspartate and glutamate metabolism Alanine, aspartate and glutamate metabolism, Aldosterone synthesis and secretion, Butanoate metabolism, Calcium signaling pathway, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, GABAergic synapse, GnRH secretion, MAPK signaling pathway, Metabolic pathways, Propanoate metabolism, Taurine and hypotaurine metabolism, Type I diabetes mellitus, Type II diabetes mellitus, Valine, leucine and isoleucine degradation, beta-Alanine metabolism 💬 | 4件: 2 2, 90, 102, 256 |
149 | Stem Cell Transplantation | - | - | - | - | 13件: 13 13, 19, 20, 46, 51, 60, 62, 65, 90, 125, 164, 234, 326 |
150 | Stem/progenitor cells transplantation | - | - | - | - | 2件: 90 90, 301 |
151 | Subretinal administration of rAAV2-VMD2-hMERTKRecombinant Adeno-Associated Virus | - | - | - | - | 1件: 90 90 |
152 | Subretinal injection of rAAV.hPDE6A | - | - | - | - | 1件: 90 90 |
153 | Subretinal injection of umbilical cord blood platelet-rich plasma (CB-PRP) | - | - | - | - | 1件: 90 90 |
154 | Timrepigene emparvovec | 1件: Timrepigene emparvovec Timrepigene emparvovec | - | - | - | 1件: 90 90 |
155 | Tocoferol | 1件: Tocopherol Tocopherol | 1件: D02332
D02332
| - | - | 1件: 90 90 |
156 | Triamcinolone | 1件: Triamcinolone Triamcinolone | 5件: D00385
D00385
,
D00983
,
D00984
,
D00985
,
D06216
| 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 10件: 35 35, 46, 56, 70, 90, 96, 107, 162, 226, 298 |
157 | Twice-daily dosage with 0.5% cyclosporine-A eyedrops | 1件: Cyclosporine Cyclosporine | 1件: D00184
D00184
| 5件: PPP3CA PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 | 33件: Alzheimer disease Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 90 90 |
158 | UF-021 | - | - | - | - | 1件: 90 90 |
159 | UF-021 (isopropyl unoprostone) | 1件: Unoprostone Unoprostone | 1件: D08661
D08661
| 1件: PTGFR PTGFR 💬 | 3件: Calcium signaling pathway Calcium signaling pathway, Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway 💬 | 1件: 90 90 |
160 | UF-021(isopropyl unoprostone) | 1件: Unoprostone Unoprostone | 1件: D08661
D08661
| 1件: PTGFR PTGFR 💬 | 3件: Calcium signaling pathway Calcium signaling pathway, Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway 💬 | 1件: 90 90 |
161 | Umbilical Cord Mesenchymal Stem Cell (UC-MSC) | - | - | - | - | 1件: 90 90 |
162 | Unoprostone | 1件: Unoprostone Unoprostone | 1件: D08661
D08661
| 1件: PTGFR PTGFR 💬 | 3件: Calcium signaling pathway Calcium signaling pathway, Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway 💬 | 1件: 90 90 |
163 | UshStat | - | - | - | - | 2件: 90 90, 303 |
164 | UshStat (SAR421869) | - | - | - | - | 2件: 90 90, 303 |
165 | VA | - | - | - | - | 3件: 90 90, 301, 302 |
166 | Valproate | 1件: Valproic acid Valproic acid | 1件: D00399
D00399
| 7件: ABAT ABAT, ALDH5A1, CACNA1G, CACNA1H, CACNA1I, GAD1, GAD2 💬 | 17件: Alanine, aspartate and glutamate metabolism Alanine, aspartate and glutamate metabolism, Aldosterone synthesis and secretion, Butanoate metabolism, Calcium signaling pathway, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, GABAergic synapse, GnRH secretion, MAPK signaling pathway, Metabolic pathways, Propanoate metabolism, Taurine and hypotaurine metabolism, Type I diabetes mellitus, Type II diabetes mellitus, Valine, leucine and isoleucine degradation, beta-Alanine metabolism 💬 | 6件: 2 2, 3, 90, 102, 233, 256 |
167 | Valproic Acid | 1件: Valproic acid Valproic acid | 1件: D00399
D00399
| 7件: ABAT ABAT, ALDH5A1, CACNA1G, CACNA1H, CACNA1I, GAD1, GAD2 💬 | 17件: Alanine, aspartate and glutamate metabolism Alanine, aspartate and glutamate metabolism, Aldosterone synthesis and secretion, Butanoate metabolism, Calcium signaling pathway, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, GABAergic synapse, GnRH secretion, MAPK signaling pathway, Metabolic pathways, Propanoate metabolism, Taurine and hypotaurine metabolism, Type I diabetes mellitus, Type II diabetes mellitus, Valine, leucine and isoleucine degradation, beta-Alanine metabolism 💬 | 10件: 3 3, 5, 26, 34, 65, 89, 90, 222, 256, 331 |
168 | Vehicle eye drops | - | - | - | - | 1件: 90 90 |
169 | Vitamin A | 1件: Vitamin A Vitamin A | 2件: D00069
D00069
,
D06543
| 2件: RARA RARA, RARB 💬 | 8件: Acute myeloid leukemia Acute myeloid leukemia, Estrogen signaling pathway, Gastric cancer, Non-small cell lung cancer, Pathways in cancer, Small cell lung cancer, Th17 cell differentiation, Transcriptional misregulation in cancer 💬 | 3件: 13 13, 53, 90 |
170 | Vitamin AD sig: 1 tablet/tid | - | - | - | - | 1件: 90 90 |
171 | Vitamin B sig: 10mg/tid | - | - | - | - | 1件: 90 90 |
172 | Vitamin E | 1件: Vitamin E Vitamin E | 1件: D02331
D02331
| - | - | 11件: 2 2, 6, 13, 20, 46, 90, 96, 97, 206, 299, 317 |
173 | Wharton's jelly derived mesenchymal stem cell | - | - | - | - | 1件: 90 90 |
174 | Zuretinol Acetate | 2件: Acetate Acetate, Zuretinol acetate | - | - | - | 1件: 90 90 |